Celularity Inc. Files 8-K: Material Definitive Agreement
Ticker: CELUW · Form: 8-K · Filed: Oct 16, 2024 · CIK: 1752828
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
Related Tickers: CELU
TL;DR
Celularity Inc. signed a big deal on Oct 9th. Details to follow.
AI Summary
On October 9, 2024, Celularity Inc. entered into a material definitive agreement. The company, formerly known as GX Acquisition Corp., is incorporated in Delaware and operates in the Pharmaceutical Preparations industry. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing indicates a significant new agreement for Celularity Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Numbers
- 001-38914 — Commission File Number (Identifies the company's SEC filings)
- 831702591 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- October 9, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the nature of the material definitive agreement entered into by Celularity Inc. on October 9, 2024?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What was Celularity Inc.'s former name?
Celularity Inc.'s former name was GX Acquisition Corp.
In which state is Celularity Inc. incorporated?
Celularity Inc. is incorporated in Delaware.
What is Celularity Inc.'s Standard Industrial Classification code?
Celularity Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported in this 8-K filing is October 9, 2024.
Filing Stats: 710 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-10-16 17:20:31
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per one-tenth of one share CELUW Th
- $5,500,000 — te consideration paid for the Asset was $5,500,000, which consisted of (i) an upfront cash
- $1,000,000 — isted of (i) an upfront cash payment of $1,000,000 (ii) an aggregate of up to $4,000,000 i
- $4,000,000 — f $1,000,000 (ii) an aggregate of up to $4,000,000 in monthly milestone payments, or the M
- $500,000 — lestone Payments, and (iii) a credit of $500,000 for the previous payment made by Celula
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex99-1.htm (EX-99.1) — 11KB
- 0001493152-24-041330.txt ( ) — 282KB
- celu-20241009.xsd (EX-101.SCH) — 4KB
- celu-20241009_def.xml (EX-101.DEF) — 30KB
- celu-20241009_lab.xml (EX-101.LAB) — 36KB
- celu-20241009_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC. Date: October 16, 2024 By: /s/ Robert J. Hariri Robert J. Hariri, M.D., Ph.D. Chairman and CEO